|
Solvay Upgrades Facility In India
Brussels based
biopharma major, Solvay group has decided to expand and upgrade its facilities
in Panoli in Gujarat.
The expansion will
result in the creation of a new, world class production unit for polyetherether
ketone (PEEK) and other materials in the ultra-performance segment of the
specialty polymers business.
The installation
will be built to provide for a natural expansion of production, resulting in a
stepwise increase in capacity as warranted by demand. It will come on stream in
the first quarter of 2008, with a production capacity of 500 metric tons per
year of KetaSpire, the new line of PEEK products developed by Solvay Advanced
Polymers.
Vincenzo Morici,
general manager of the specialty polymers strategic business unit, Solvay said,
"The expansion of the Panoli plant and the launch of our new KetaSpire PEEK
materials are instrumental in our high and ultra performance polymers strategy.
With these expansion and upgrade plans, we can capitalise on the inherent
strengths of Panoli, which contributed Outstanding talent to the Group, as well
as a prime location at the heart of the world's fastest growing economies."
Solvay employs
some 30,000 people in 50 courtiers. In 2005 its consolidated sales amounted to
$10.75 billion generated by its three activity sectors, chemicals, plastics and
pharmaceuticals.
(Ref :
Biospectrum November 2006)
Nano Interface Technology Explores India Operations
Washington DC
based Nano Interface Technology is looking to capture the country's booming
orthopedic and dental implants market. The company's president and CEO, Dr C P
Singh met with Ram Vilas Paswan, minister of chemicals, fertilizers and steel to
explore the possibility of establishing a factory in India for orthopedic and
dental implants.
India is projected
to be the largest market for orthopedic and dental implants in the next five
years. The hip, knee and dental implants have a worldwide market size of $15
billion dollar with growth rate of 15-25 percent. NITI has developed
nanotechnology-derived economical ultra-pure coatings for orthopedic and dental
implants.
Dr Singh also
discussed business opportunity with Dr Ajay Kumar, president-elect of the Indian
Medical Association which has 1,70,000 physicians and surgeons as members.
Dr Kumar said,
"Nanotechnology can lead to paradigm shift in the market shares of the various
existing medicines and devices due to the better performances by new
formulations or devices. The first nanotechnology based medicine, Neoral - a
nano-size formulation of Cyclosporin, has been in the market for 10 years with
market capitalization of $1 billion."
(Ref :
Biospectrum November 2006)
|
